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Several studies report signs of slight infection prior to death in cases of sudden infant death
syndrome (SIDS). Based on this, a hypothesis of an altered immunological homeostasis has
been postulated. The cytokines are important cellular mediators that are crucial for infant
health by regulating cell activity during the inflammatory process. The pro-inflammatory
cytokines favor inflammation; the most important of these are IL-1α, IL-1β, IL-6, IL-8, IL-12, IL-
18,TNF-α, and IFN-γ.These cytokines are controlled by the anti-inflammatory cytokines.This
is accomplished by reducing the pro-inflammatory cytokine production, and thus counter-
acts their biological effect.The major anti-inflammatory cytokines are interleukin-1 receptor
antagonist (IL-1ra), IL-4, IL-10, IL-11, and IL-13. The last decade there has been focused on
genetic studies within genes that are important for the immune system, for SIDS with a
special interest of the genes encoding the cytokines. This is because the cytokine genes
are considered to be the genes most likely to explain the vulnerability to infection, and sev-
eral studies have investigated these genes in an attempt to uncover associations between
SIDS and different genetic variants. So far, the genes encoding IL-1, IL-6, IL-10, and TNF-α
are the most investigated within SIDS research, and several studies indicate associations
between specific variants of these genes and SIDS.Taken together, this may indicate that in
at least a subset of SIDS predisposing genetic variants of the immune genes are involved.
However, the immune system and the cytokine network are complex, and more studies
are needed in order to better understand the interplay between different genetic variations
and how this may contribute to an unfavorable immunological response.
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INTRODUCTION
Sudden infant death syndrome (SIDS) is defined as the sudden
unexpected death of an infant <1 year of age, with onset of the
fatal episode apparently occurring during sleep, that remains unex-
plained after a thorough investigation, including performance of
a complete autopsy and review of the circumstances of death and
the clinical history (1). Even though there have been numerous
studies trying to understand the pathophysiological mechanisms
of SIDS, we still not fully understand what causes these deaths,
or how to prevent them. The fatal triangle developed by Rognum
et al. (2) suggest that SIDS occur when an infant at the same time is
in a vulnerable developmental stage, with a rapid development of
both the central nervous system (CNS) and the immune system,
has predisposing factors such as an unfortunate genetic “make-
up” or brainstem astrogliosis, and that trigger events such as slight
infection, prone sleeping, maternal smoking, or overheating are
present (Figure 1) (2).
SIDS AND INFECTION
There is compelling evidence for a dysfunctional immune response
in SIDS, and already in 1947, Werne et al. suggested that respi-
ratory infection was the cause of death in an otherwise healthy
infant (3). Since then, there have been numerous reports and
papers describing signs of slight infection in SIDS infants (4–7).
An immunological “overreaction” has been postulated since about
half of the SIDS victims have had symptoms of slight infection in
the days before death (8, 9).
Arnon et al. have hypothesized that some infants might suffer
respiratory arrest due to botulinum toxin produced by Clostridium
botulinum (10). From a cohort of 280 infants, they showed that
botulinum toxin was present in 10 infants, of which 9 had been
diagnosed as SIDS (10). Stoltenberg et al. have reported immune
stimulation in both the upper airways and intestines, showing that
SIDS had higher number of IgM immunocytes in the tracheal wall
than controls, but significantly lower numbers of IgA and IgM
immunocytes than cases of infectious death (11). In the duodenal
mucosa, the number of IgA immunocytes was higher in SIDS cases
than in controls. These findings indicate that the mucosal immune
system is activated in a large proportion of SIDS (11). It is also
shown that SIDS has higher IgG and IgA immunocyte density in
the palatine tonsillar compartments than controls (12). Further-
more, salivary glands have a higher number of CD45+ stromal
leukocytes, as well as intensified epithelial expression of HLA-DR
and secretory component, and increased endothelial expression
of HLA class I and II (13). These observations confirm that the
immune system is activated in SIDS, probably with release of cer-
tain cytokines that are known to up-regulate epithelial expression
of HLA-DR and secretory component (13).
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A real breakthrough for the immunological overreaction theory
was the demonstration by Vege et al. (8, 14), who showed that SIDS
victims who have had signs of slight infection prior to death had
both increased number of IgA immunocytes and HLA-DR expres-
sion in their laryngeal mucosa, as well as increased levels of IL-6 in
their cerebrospinal fluid (CSF). In fact, half of the SIDS victims had
CSF IL-6 concentrations in the same range as victims of meningi-
tis and septicemia (8). A further support for the infection theory
is a study performed on registry data from Norway and Sweden,
which suggests that there is a co-variation between epidemics of
whooping cough and SIDS (15). The association was stronger in
Sweden than in Norway, which may reflect that Swedish infants are
not vaccinated against Bordetella pertussis while the Norwegians
infants are (15).
Stray-Pedersen et al. showed that SIDS victims with positive
Helicobacter pylori stool antigen (HpSA) immunoassay had ele-
vated IL-6 in the CSF compared to SIDS victims with negative
HpSA test (16). Furthermore, detection of Helicobacter pylori anti-
gen in stool was found associated with SIDS and death due to infec-
tion, indicating that this bacteria may represent a contributing
factor to sudden death during the first months of life (16).
Surfactant protein A (SP-A) is a protein produced in the lungs,
with a major purpose to reduce the surface tension at the alveolar
air–liquid interface. Furthermore, it takes part in regulation of the
inflammatory process. Interestingly, with regard to SIDS, there is
a drop in alveolar SP-A expression in the first months after birth
(17), corresponding to the classical age peak of SIDS. Thus, it may
be hypothesized that this transient low expression of SP-A may be
a part of the increased vulnerability for SIDS at that age (17).
It is also suggested that Staphylococcus aureus (S. aureus) are
involved in events leading to SIDS (18). Based on observations
from samples collected from the intestinal tract in SIDS compared
with samples from feces from a group of healthy controls, it was
shown that S. aureus and staphylococcal enterotoxins were more
prevalent in SIDS. However, as much as 40% of the controls were
positive for S. aureus, indicating that this bacteria is common in
infants, and that the detection may not be seen as a support for
the diagnosis of SIDS (18).
Another study investigated pyrogenic toxins of S. aureus in
SIDS infants from different countries (19). The study reported
these pyrogenic toxins in >50% of SIDS infants from three
FIGURE 1 |The hypothesis of a fatal triangle in SIDS. Modified with
permission from Rognum and Saugstad (2).
different countries; Scotland, France, and Australia, and suggest
that further investigation into the effect of the toxins may be
important (19). A study by Blackwell et al. found that the preva-
lence of S. aureus in nasopharyngeal flora was significantly higher
in SIDS cases compared to age-matched healthy controls (20). Fur-
thermore, SIDS found in a prone sleeping position more often had
symptoms of slight infection prior to death than the babies put to
sleep on their back.
The relationship between laryngeal immune stimulation, clini-
cal signs of slight infection prior to death, and high levels of IL-6 in
CSF may indicate an interaction between the immune system and
the CNS (14). The assumption of such a relationship is strength-
ened by the recently reported increased IL-6 receptor expression
on serotonergic cells in brain stem nuclei involved in respiratory
regulation in SIDS cases compared to controls (21). Almost half
of the investigated SIDS cases had signs of mild infection prior to
death, and the study provides evidence for aberrant interactions in
SIDS infants between IL-6 and the area of the brain stem involved
in protective responses to hypercapnia, potentially induced by the
combined effect of prone position and mild infection.
COMPLEMENT COMPONENT C4
The first gene involved in the immune system to be investigated
with regard to SIDS was the gene encoding complement com-
ponent C4. This gene consists of two loci, C4A and C4B, and is
highly polymorphic. Partial deletions of the C4 gene are common
and found in 5–20% of Caucasians (22). The C4 gene has been
investigated in both German and Norwegian SIDS victims, but
none of these studies detected any differences between SIDS cases
and controls with regard to allele frequencies (23–25). However,
two of the studies revealed an association between slight infec-
tions prior to death and partial deletions of either the C4A or the
C4B gene, which may indicate that this combination represents
increased risk of sudden infant death (Table 1) (23, 25).
Table 1 | C4 and HLA-DR gene variants investigated in cases of SIDS.
Gene Variant SIDSa Controlsa Findings, reference
C4 Deletion
of gene
40 47 In SIDS: association between
slight infection prior to death
and partial C4 deletions
(p=0.013) (23)
Deletion
of gene
39 183 No significant findings (24)
Deletion
of gene
104 84 In SIDS: association between
slight infection prior to death
and partial C4 deletions
(p=0.039) (25)
HLA-DR Allele
analyses
40 47 No significant findings (23)
39 183 HLA-DR2 associated with
SIDS (p=0.002) (24)
Allele
analyses
16 181 Underpowered, no significant
findings (26)
aNumber of cases.
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HLA-DR
Numerous diseases are associated with different alleles of the major
histocompatibility complex, and HLA-DR has been investigated in
a few SIDS victims (Table 1). There has been reported a signifi-
cant decreased frequency of HLA-DR2 in a study including 39
SIDS cases and 183 controls (24). However, Schneider et al. (23)
investigated 40 SIDS cases and found no significant difference in
the HLA-DR gene frequencies between the SIDS cases and the
controls, an observation, which was later confirmed in a study of
16 Norwegian SIDS cases (26).
IL-10
The genes most likely to explain the vulnerability to infection seen
in SIDS are the cytokine genes. Several studies have investigated
these genes in an attempt to uncover associations between SIDS
and different genetic variants, and one of the most investigated
is IL-10.
IL-10 is an important immune regulatory cytokine that down-
regulates the production of pro-inflammatory cytokines, such as
IL-6 and TNF-α. Levels of IL-10 control the balance between
inflammatory and humoral responses, and IL-10 therefore plays an
important role in the development of infectious disease. Variability
in IL-10 production has a hereditary component of approxi-
mately 75%, and the SNPs in the promoter region in position
−1082, −819, and −592, as well as the microsatellite IL-10R
and IL-10G, are collectively responsible for the production of the
protein (27, 28).
The first study investigating the IL-10 gene in SIDS was by Sum-
mers et al., who investigated 23 SIDS cases and found that SIDS
was associated with both the ATA haplotype and the−592A allele
(29). However, according to the authors, babies who died of other
causes might have been included in the SIDS group, which may
have influenced the results (29). A Norwegian study of 214 SIDS
cases was unable to confirm the association to SIDS, but found an
association between the ATA haplotype and the ATA/ATA geno-
type and infectious death (Table 2) (30). The latter study also
investigated the microsatellites, and found a higher percentage of
the genotypes G21/G22 and G21/G23 in cases of infectious death
compared to SIDS, and a higher percentage of G21/G22 in the
SIDS cases compared to controls, while there were no differences
between the groups for the IL-10R area (Table 2) (30). Subsequent
studies investigating this gene have reported conflicting results, a
small study investigating that 38 SIDS cases found an association
between −592A and ATA/ATA and SIDS (31), while other studies
did not (Table 2) (32, 33). An Australian study investigated the
−1082A/G polymorphism in SIDS cases and SIDS parents from
different countries, but did not find any differences in genotype
frequency between this combined SIDS population and controls,
neither between SIDS parents and controls (Table 2) (34). This
study also investigated the influence of genotype and smoking on
IL-10 responses. They found that the pooled data from smokers
had significantly lower levels of IL-10 responses to TSTT, but there
were no significant differences for smokers compared with non-
smokers for the three genotypes (34). The lowest levels of IL-10
responses were observed among smokers who were homozygous
for the −1082A allele, which is most prevalent among Aborigi-
nal Australians and Bangladeshis. This is interesting, as the major
difference between the risk factors for SIDS in these two groups is
the level of exposure of infants to maternal smoking.
Based on the findings in these studies, one might speculate
that in some situations an infant with an unfavorable IL-10 geno-
type may exhibit aberrant IL-10 production, which in turn leads
to a disturbed immunological homeostasis and an increased risk
for sudden death. This may be especially unfavorable if exposed
to smoking, in particular in utero or if a smoking mother is
breast-feeding.
IL-6
IL-6 is an acute phase protein that induces B- and T-cell growth
and differentiation. IL-6 is also an important mediator of fever,
and influences the effect of other cytokines. The first study of
the IL-6 gene in cases of SIDS was a British study that included
common polymorphisms in the genes encoding IL-4, IL-6, IFN-γ,
TGF, and VEGF (35). They found significant differences for the
genes encoding IL-6 and VEGF: the genotypes IL-6−174GG, and
VEGF−1154AA were more frequent in SIDS cases than in controls
(Table 2) (35). Even though only a small number of SIDS cases
were included, the authors suggest that the causation of SIDS is
related to both fetal lung development and an infant’s innate ability
to mount an inflammatory response to infection (35). The find-
ings in the IL-6 gene have been confirmed in a study of Australian
SIDS cases (36), but not in a Norwegian study (Table 2) (37). In the
Australian study, it was in addition found a relationship between
IL-6 responses to endotoxin, IL-6 genotype, and smoking status
(36). A study by Ferrante et al., investigated the −572G/C poly-
morphism in the IL-6 gene in 148 SIDS cases, but it did not find
any association between this SNP and SIDS (Table 2) (38). A study
evaluating the correlation between HLA-DR expression in laryn-
geal mucosa and interleukin gene variation found that 12 of 13
SIDS cases (92%) with high HLA-DR expression, prone sleeping
position, and sighs of infection prior to death had the IL-6 −176
CG/CC genotypes (p= 0.01) (45).
IL-1
IL-1 is a pro-inflammatory cytokine that induces the synthesis of
acute phase proteins, and also induces fever. There are two struc-
turally distinct forms of IL-1: IL-1α, which is the acidic form and
IL-1β, which is the neutral form. IL-1 is regulated by the compet-
itive antagonist IL-1Ra. The polymorphisms IL-1β −511C/T and
IL-1Ra +2018T/C have a significant effect on the IL-1β levels. An
Australian study investigated a combined SIDS group with cases
from different countries with European controls, but did not find
any association between those SNPs and SIDS (Table 2) (40). It
was, however, shown that smoking had a significant effect on both
IL-1β and IL-1ra responses to endotoxin, and that this effect dif-
fered according to genotype (40). This finding is highly interesting,
since maternal smoking is one of the most well-known risk factors
for SIDS (9, 46, 47).
A Norwegian study investigated a variable number of tandem
repeat (VNTR) in intron 6 and the SNP in+4845G/T in the IL-1α
gene, as well as the−511C/T polymorphism in the gene encoding
IL-1β and aVNTR in intron 2 of the gene encoding IL-1ra (Tables 2
and 3) (39). When investigating each polymorphism separately, no
association to SIDS was found. However, when combining VNTR
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Table 2 | Interleukin and cytokine gene polymorphisms investigated in cases of SIDS.
Gene Variant SIDSa Controlsa Findings, reference
IL-10 −1082A/G 214 136 ATA haplotype associated with infectious death (p=0.007), no association to SIDS (30)
−819C/T
−592A/C
−1082A/G 38 330 −592A allele associated with SIDS (p=0.004) (31)
−819C/T
−592A/C
−1082A/G 23 100 Underpowered, no significant findings (32)
−819C/T
−592A/C
−1082A/G 123 406 No significant findings (33)
−592A/C
−1082A/G 85 118 No significant findings (34)
IL-10G 214 136 G21/G22 associated with SIDS (p=0.005) (30)
IL-10R 214 136 No significant findings (30)
IL-6 −174G/C 25 136 −174G associated with SIDS (p=0.034) (35)
−174G/C 96 467 −174GG associated with Australian SIDS (p=0.02) (36)
−174G/C 175 71 No significant findings (37)
−572G/C 148 131 No significant findings (38)
IL-1α +4845G/T 204 131 No significant findings (39)
VNTR intron 6 204 131 VNTR A1A1/+4845TT combination associated with SIDS (p<0.01) (39)
IL-1Ra +2018T/C 87 122 No significant findings (40)
VNTR intron 2 204 131 No significant findings (39)
VNTR intron 2 113 218 2/2 genotype and A2 allele more common in SIDS (p=0.026 and p=0.004, respectively) (41)
VNTR intron 2 49 94 A2 allele associated with SIDS (p=0.007) (42)
TNF-α −308A/G 23 330 Underpowered, no significant findings (29)
−238 G/A 23 100 Underpowered, no significant findings (32)
−308G/A
−1031T/C 148 131 −238GG associated with SIDS (p=0.022). SNP profiles −1031CT/−238GG/−857CC/−308GG and
−1031TT/−238GG/−857CC/−308AA associated with SIDS (p=0.03 and p=0.05, respectively) (43)−857C/T
−308G/A
−244G/A
−238G/A
−308A/G 89 267 −308AA associated with Australian SIDS (p=0.03) (44)
IL-8 −251A/T 148 131 IL-8 −251AA/AT and IL-8 −781CT/TT more frequent in SIDS found dead prone (p=0.006 for both) (38)
−781C/T
aNumber of cases.
Genes and SNPs with no significant findings are given inTable 3.
and SNP genotypes, an association between the gene combination
IL-1αVNTR A1A1/+4845TT and SIDS was disclosed, 16% of the
SIDS cases had this combination compared to 1.8% of the controls
(p< 0.01) (Table 2). In the SIDS group, it was also found that the
genotypes IL-1β −511CC/CT were significantly more frequent in
the SIDS victims who found dead in a prone sleeping position
compared with SIDS victims who found dead in other sleeping
positions (p= 0.004) (39).
The 89bp VNTR in the IL-1Ra gene have also been investigated
in Australian SIDS cases, where it was found that carriage of the
2/2 genotype increased the risk for SIDS compared with the pre-
dominant 1/1 genotype (Table 2) (41). Homozygous carriers of
allele 2 show a more severe and also prolonged pro-inflammatory
immune response compared to other IL-1Ra genotypes (49),
which may contribute to the vulnerability to infection seen in
SIDS. A smaller study investigating the IL-1ra VNTR in 13 SIDS
cases and 103 controls found an association between A2A2 and
SIDS (Table 1) (42).
TUMOR NECROSIS FACTOR ALPHA
Tumor necrosis factor alpha (TNF-α) is a transmembrane pro-
tein produced as a result of the presence of bacterial toxins.
TNF-α is an important regulator of immune cells, in addition
to stimulate inflammation and controlling viral replication.
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Table 3 | Genes and SNPs with no significant findings with regard to
SIDS.
Gene Variant SIDSa Controlsa Findings, reference
IL-1β −511C/T 93 122 (40)
−511C/T 204 131 (39)
TGF-β +869C/T 23 330 Underpowered study (29)
+869T/C 25 136 Underpowered study (35)
IFN-γ +874A/T 25 136 Underpowered study (35)
+874A/T 148 131 (38)
+874A/T 69 221 No association to SIDS, but
strong tendency (p=0.06) (48)
IL-4 −590C/T 25 136 Underpowered study (35)
aNumber of cases.
Two smaller studies have investigated the TNF-α polymor-
phisms −238A/G and −308A/G, but did not find any associ-
ation to SIDS (Table 2) (29, 32). Five SNPs in the promoter
region of the TNF-α gene have been investigated in a Nor-
wegian SIDS population (43). The study found an association
between the genotype −238GG and SIDS (Table 2). In addi-
tion, SNP profiles −1031CT/−238GG/−857CC/−308GG and
−1031TT/−238GG/−857CC/−308AA found more often in SIDS;
this may therefore be unfavorable SNP combinations (43). An Aus-
tralian study investigated the −308G/A polymorphism in SIDS
cases from different countries, and found a significantly higher
proportion of the AA genotype among Australian SIDS cases
compared to controls (Table 2) (44).
OTHER CYTOKINES
In addition to the genes mentioned above have also SNPs in the
genes encoding IL-4 IL-8, IL-12, IL-13, IL-16, IL-18, TGF-β1, and
INF-γ been investigated in SIDS (29, 35, 38). A Norwegian study
found that the genotypes IL-8−251AA/AT and IL-8−781CT/TT
were significantly more frequent in SIDS cases found dead in a
prone sleeping position compared with SIDS cases found dead in
other sleeping positions (Table 2) (38). Further, the IL-8 genotypes
−251AA/AT and −781CT/TT were more often observed in SIDS
cases with positive HLA-DR and one or more risk factors com-
pared with SIDS cases with negative HLA-DR, no infection, and
supine sleeping (45). An Australian study investigating SIDS cases
from different countries found a marginal association with the
IFN-γ +874AA genotype and SIDS (Table 3) (48).
OTHER IMMUNE GENES
An increased vulnerability to infection may also be due to genetic
variation in the genes encoding G-proteins. The most investigated
polymorphism in the Gβ3 gene is C825T, and it is shown that T-
allele results in increased G-protein-mediated signal transduction
compared to the C-allele (50). Most interleukin-receptors are G-
protein coupled, and an association between the Gβ3 825T allele
and increased cell function has been reported (51). A study looking
at the C825T polymorphism in SIDS victims, cases of infectious
death, and live infant controls, revealed no difference in genotype
frequency between SIDS cases and controls (52), but an associ-
ation between the CC genotype and infectious death was found
(p= 0.016). This observation may indicate that the presence of
the 825T allele exerts a protective effect toward serious infection,
perhaps through enhanced G-protein signaling.
Surfactant protein A and surfactant protein D (SP-D) are
humoral molecules involved in the innate host defense against var-
ious bacterial and viral pathogens. Ten common SNPs that might
influence expression of the genes encoding these two surfactants
have been investigated in SIDS cases and controls (p= 0.08) (53).
No difference in genotype distribution was found, even though
there was a tendency for the most common SP-A haplotype,
6A2/1A0, to be overrepresented in cases with low immunohisto-
chemical SP-A expression (53). None of the other SP-A haplotypes
was associated with high or low SP-A expression, and the same was
true for the two investigated SP-D SNPs (53).
Polymorphisms that influence the expression of toxin recep-
tors could contribute to SIDS, at least in the cases where there
is evidence of toxin involvement. One gene that influences the
expression of receptors for staphylococcal enterotoxin B and C in
humans are the TCRBV3S1 gene, and a C–T SNP in a recombina-
tion signal sequence (RSS) gene region is shown to influence the
expression of the gene (54). This SNP have been investigated in
48 Australian SIDS cases and 96 controls, but no differences were
found between SIDS cases and controls (55).
Another protein that might be of importance with regard to
endotoxins in SIDS is CD14. The TT genotype of the CD14
−260C/T polymorphism causes a significantly higher density of
CD14 receptor expression in monocytes, which makes the individ-
ual more sensitive to endotoxin than those with the CC genotype
(56). This polymorphism has been investigated in an Australian
cohort of 116 SIDS cases and 228 controls (57). No differences were
found in genotype frequencies between SIDS cases and controls,
and the authors conclude that the CD14−260C/T polymorphism
is unlikely to be involved in SIDS (57).
DISCUSSION
The many genetic studies within immune genes in SIDS strongly
suggest that these infants do have a combination of geno-
types making them vulnerable to infections. The predispositions
reported so far are mostly common SNPs with association to SIDS,
but genetic variants with strong dominance in SIDS still remains
to be uncovered. However, the challenges within genetic studies of
SIDS are many. First and foremost is the fact that the SIDS diag-
nosis is an exclusion diagnosis and important challenge, and even
though a great effort has been done in order to standardize is still
different diagnostic criteria used in different countries. This might
result in that infant with other causes of death, such as accidental
asphyxia, or interstitial pneumonia might be included in the SIDS
group, and thus camouflage a true genetic association.
Another challenge to genetic studies is the genetic variation
between different ethnic groups, which makes it difficult to com-
pare results between different studies without including a potential
error. This must be taken into account when investigating SIDS. In
addition, the investigated SIDS populations are often small, which
make the genetic studies more difficult to interpret. The number
of SIDS cases a year in, for instance, Norway is at the moment
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about 20, making it difficult and time consuming to be able to
collect a large number of cases.
The fact that the number of cases and controls in each study
often is small in relation to the number of statistical tests that
is undertaken increases the risk of false negatives. Several studies
include <25 SIDS cases, which makes it difficult to draw any firm
conclusions. Even so, to our best of knowledge are all studies inves-
tigating immune genes in SIDS included in Tables 1–3, in order to
give a comprehensive survey of the research done regarding this
topic so far. A large scale GWAS study might be an important next
step. The drawback of this method is, however, that important
information may be lost due to the corrections that have to be
made when investigating such a vast number of polymorphisms,
in addition to the problem with limited number of cases. Even so,
one might find polymorphisms that could be expected to have a
small effect on the SIDS risk. This may be important as these gene
variants may point directly to the underlying cause, such as for
instance a sub-optimal immune reaction.
Despite the limitations, association studies are still able to
report several genetic variations within many immune genes that
might be associated with SIDS (Tables 1 and 2). This strongly
suggest that these genes are of importance and hopefully in the
future can provide even better and more accurate understanding
of the role of the immune system in SIDS. However, immunology
is a complicated biological field, and perhaps the most interest-
ing frontiers in the genetics of immunity arise in the interaction
between immune activity and other physiological or developmen-
tal processes. A better understanding of how genetic variation
might influence the functional effect of the encoded proteins and
how this can lead to a fatal outcome is important, and hopefully,
with the new possibilities present within genetic research, this can
be elucidated. Further would an in-depth analysis of the corre-
lation between genotypes, interleukin response, and risk factors,
such as smoking exposure, in different SIDS populations be inter-
esting and might shed light on the involvement of the immune
response in these deaths.
CONCLUSION
The studies so far suggest that some SIDS infants may have a
genetic vulnerability in the regulation of the immune system. An
unfortunate combination of polymorphisms in genes involved in
the immune system, in particular in the cytokine genes, may lead
to an imbalance in the immune response and render the infant
unable to cope with an infection. However, the immune system and
the cytokine network are complex, and more studies are needed
in order to better understand the interplay between different
genetic variations and how this may contribute to an unfavorable
immunological response. The associations observed so far between
different polymorphisms and SIDS and environmental factors for
SIDS most likely represent only a small part of genetic patterns
that may result in an unfortunate immunological reaction.
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